The story of Tiffany Mane reading “Financial Feminist” by Tori Dunlap on her daily commute is just one example of the growing movement to empower women through financial education. Mane’s experience sparked curiosity from those around her, leading to discussions about personal finance and the importance of women taking control of their economic lives. This
0 Comments
The Social Security Administration recently announced a final rule that will significantly impact Supplemental Security Income (SSI) beneficiaries by preventing food assistance from reducing their monthly payments. SSI provides financial support to disabled individuals, the blind, or those age 65 and older with limited income or resources. This change is set to take effect on
0 Comments
Xiaomi, the Chinese smartphone giant, has made waves with its recent announcement to enter the electric car market. The company’s CEO, Lei Jun, revealed that Xiaomi’s first car, the SU7, will be priced significantly lower than Tesla’s Model 3, marking the beginning of what could be a fierce price war in China’s competitive electric car
0 Comments
Walgreens recently reported its fiscal second-quarter sales results, which exceeded Wall Street’s expectations. However, the company decided to adjust its full-year adjusted earnings outlook, mainly due to the challenging retail environment in the U.S. Despite a high net loss for the quarter and impairment charges related to VillageMD clinics, Walgreens is focused on transforming from
0 Comments
In the fast-paced world of finance, a new company is making waves with its innovative approach to integrating artificial intelligence and investing. iFi AI, led by CNBC senior analyst and commentator Ron Insana, is set to launch with a mission to assist individual traders in making informed buy and sell decisions. By utilizing AI models
0 Comments
When it comes to investing in cryptocurrency like Bitcoin, it’s important to approach it with caution. Katherine Dowling, the general counsel and chief compliance officer at Bitwise Asset Management, compares investing in cryptocurrency to using cayenne pepper – a little goes a long way. This analogy highlights the volatility and risk associated with digital assets
0 Comments
The blockbuster diabetes drug Ozempic may have a manufacturing cost of less than $5 a month, according to a study released by researchers at Yale University, King’s College Hospital, and Doctors Without Borders. However, the list price set by Novo Nordisk in the U.S. is close to $1,000 per month before insurance. This stark difference
0 Comments